March 2, 2026
To support the delivery of high-quality care for our members, we are implementing changes to our Medicare Part D formularies for the 2026 benefit year. Please note, this is not an all-inclusive listing of the changes going into effect.
Below is a list of products that will require prior authorization starting April 1st, 2026.
Part D Insulin Syringes:
BD Insulin Syringe 29G X 1/2" 1 mL
BD Insulin Syringe Ultrafine 30G X 1/2" 0.5 mL, 1 mL
BD Insulin Syringe Ultrafine 31G X 5/16" 0.5 mL, 1 mL
Easy Touch Insulin Syringe 30G X 5/16" 0.5 mL
Embecta Insulin Syringe U/F 30G X 1/2" 1 mL
Embecta Insulin Syringe U/F 31G X 15/64" 0.5 mL, 1 mL
Embecta Insulin Syringe U/F 31G X 5/16" 0.5 mL, 1 mL
Monoject Insulin Syringe 31G X 5/16" 1 mL
Monoject Insulin Syringe U-100 1 mL
True Comfort Pro Insulin Syr 30G X 5/16" 0.5 mL
UltiCare Insulin Safety Syr 29G X 1/2" 0.5 mL
UltiCare Insulin Syringe 30G X 5/16" 0.5 mL
UltiCare Insulin Syringe 31G X 1/4" 0.5 mL
*Prior authorization does not apply to patients with a history of insulin use or patients currently filling
For the most up-to-date information regarding our formularies, please visit Hpplans.com/formularies. For more information, call our Pharmacy department at 1-866-841-7659 or our Provider Services Helpline at 1-888-991-9023 (Monday to Friday, 9 a.m. to 4:30 p.m.).
Thank you for your cooperation in improving the quality of care you deliver to your patients and our members.